Each year, 500.000 women undergo mesh surgery due to stress urinary incontinence. This has so far been their best available option, despite the risks and the fact that mesh surgery may not work at all. The risk benefit ratio is so bad, that in 2017 New Zealand, and in July 2018, UK NHS suspended mesh surgery.

A much better solution is urgently needed!

We have developed and clinically tested a unique medical device, Obtinu, which can help thousands of women in their everyday life. 

Obtinu is a single-use, very soft, silicone tube, that the user herself inserts in the urethra each morning. The tube stays in place all day, and has an inner valve, which restores control over bladder voiding. The tube is pulled out and discarded in the evening, before going to bed.

Three groups of users have tested Obtinu in clinical trials at the Copenhagen University Hospital. The doctors conclude, that Obtinu is safe and immediately efficient.

As Obtinu is both comfortable and easy to use, we have a high user approval.

The graphs below show the impressive efficiency, observed for a group of 16 severely incontinent test users. You can read more about these results in the section “Clinical”. 

Klinisk test 3.png

In 2019, we will start a long term study, in which we will see how the daily life is improved and at the sme time quantify the user adoption rate. 

Our design is protected by two patents, granted in EU and China, pending in USA.

 Guardian headline, July 9th, 2018. Guardian research found one in 15 women given a mesh implant later required surgery to have it removed.

Guardian headline, July 9th, 2018. Guardian research found one in 15 women given a mesh implant later required surgery to have it removed.